OGN - Organon & Co.
NEXT EARNINGS:
Apr 30, 2026
EPS Est: $0.77
|
Rev Est: $1.5B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$6.50
DETAILS
HIGH:
$8.00
LOW:
$5.00
MEDIAN:
$6.50
CONSENSUS:
$6.50
DOWNSIDE:
20.15%
Market Cap:
2.12B
Volume:
4,680,018
Avg Volume:
5,341,923
52 Week Range:
6.18-16.18
Sector:
Healthcare
Industry:
Drug Manufacturers - General
Beta:
0.55
Last Dividend:
$0.34
Exchange:
NYSE
Country:
US
Employees:
10,000
IPO Date:
2021-05-14
EPS (TTM):
0.72
P/E Ratio:
9.95
Revenue (TTM):
6.22B
Total Assets:
N/A
Total Debt:
8.64B
Cash & Equiv:
574.00M
Rev Growth (5Y):
-1.0%
EPS Growth (5Y):
-39.0%
FCF Growth (5Y):
-26.1%
ROCE:
N/A
Debt/Equity:
9.54
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-12 | $0.63 | $0.73 | -13.7% | $1.5B | $1.5B | +0.5% |
| 2025-11-10 | $1.01 | $0.93 | +8.6% | $1.6B | $1.5B | +5.3% |
| 2025-08-05 | $1.00 | $0.94 | +6.4% | $1.6B | $1.6B | +2.1% |
| 2025-05-01 | $1.02 | $0.89 | +14.6% | $1.5B | $1.5B | -1.5% |
| 2025-02-13 | $0.90 | $0.92 | -2.2% | $1.6B | $1.6B | 0.0% |
| 2024-10-31 | $0.87 | $0.90 | -3.3% | $1.6B | $1.6B | +1.2% |
| 2024-08-06 | $1.12 | $1.06 | +5.7% | $1.6B | $1.6B | -1.5% |
| 2024-05-02 | $1.22 | $0.97 | +25.8% | $1.6B | $1.6B | +3.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.22B | 6.40B | 6.26B | 6.17B | 6.30B | 6.53B | 7.78B | 9.78B | 10.50B |
| Net Income | 187.00M | 864.00M | 1.02B | 917.00M | 1.35B | 2.16B | 3.22B | 2.15B | 1.80B |
| EPS | 0.72 | 3.36 | 4.01 | 3.61 | 5.33 | 8.52 | 12.71 | 8.51 | 7.11 |
| Total Assets | 0 | 13.10B | 12.06B | 10.96B | 10.68B | 10.11B | 10.55B | 10.49B | N/A |
| Total Debt | 8.64B | 9.04B | 8.93B | 9.11B | 9.36B | 31.00M | 186.00M | 149.00M | N/A |
| Cash & Equivalents | 574.00M | 675.00M | 693.00M | 706.00M | 737.00M | 12.00M | 319.00M | 244.00M | N/A |
| Operating Cash Flow | 0 | 939.00M | 799.00M | 858.00M | 2.46B | 2.19B | 2.77B | 3.69B | 3.42B |
| Free Cash Flow | 0 | 588.00M | 538.00M | 431.00M | 1.97B | 1.91B | 2.67B | 3.59B | 3.33B |
| FCF per Share | N/A | 2.29 | 2.11 | 1.70 | 7.77 | 7.53 | 10.57 | 14.17 | 13.17 |
| Book Value | 906.00M | 472.00M | (70.00M) | (892.00M) | (1.51B) | 5.49B | 7.04B | 6.35B | N/A |
| Cash & ST Investments | 574.00M | 675.00M | 693.00M | 706.00M | 737.00M | 12.00M | 319.00M | 244.00M | N/A |
| ROC Equity | 0.21 | 1.83 | N/A | N/A | N/A | 0.39 | 0.46 | 0.34 | N/A |